Pełny tekst tego artykułu nie jest dostępny w BazHum.
TYTUŁ ARTYKUŁU
Pathogenetic rationale for the use of immunomodulating and systemic enzyme therapy in treatment of nulliparous women with endometrioid ovary tumors
Zacytuj
CZYSTY TEKST
O. S. Shapoval, L. L. Vorontsova, Pathogenetic rationale for the use of immunomodulating and systemic enzyme therapy in treatment of nulliparous women with endometrioid ovary tumors, Journal of Education, Health and Sport, 2015 / Tom 5 / Numer 1, s. 75 - 86
BIBTEX
O. S. Shapoval and L. L. Vorontsova. Pathogenetic rationale for the use of immunomodulating and systemic enzyme therapy in treatment of nulliparous women with endometrioid ovary tumors. Journal of Education, Health and Sport, 5(1):75–86, 2015.
Pokaż kod BibTeX
@article{bazhum61755,
author = {Shapoval, O. S. and Vorontsova, L. L.},
title = {{Pathogenetic rationale for the use of immunomodulating and systemic enzyme therapy in treatment of nulliparous women with endometrioid ovary tumors}},
journal = {Journal of Education, Health and Sport},
year = {2015},
volume = {5},
number = {1},
pages = {75--86},
issn = {2391-8306},
url = {https://bazhum.muzhp.pl/articles/61755}
}